✦ LIBER ✦

A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma

✍ Scribed by Takashi Kanematsu; Takashi Matsumata; Ken Shirabe; Keizo Sugimachi; Shigeru Sakamoto; Hajime Nawata; Kanehiro Hasuo; Hiroshi Honda; Kouji Masuda

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 537 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930401)71:7<2181::aid-cncr2820710703>3.0.co;2-3

No coin nor oath required. For personal study only.

✦ Synopsis

Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors compared the therapeutic results achieved by surgery and TAE in patients with early-stage HCC and well-preserved liver function, who were independently treated by two different policies in two separate departments of the same university hospital during the same period.

Methods. From 1983 to 1987, 67 patients with HCC underwent hepatic resection at the

📜 SIMILAR VOLUMES

Transcatheter hepatic arterial embolizat

Transcatheter hepatic arterial embolization followed by hepatic resection for the spontaneous rupture of hepatocellular carcinoma

✍ Miin-Fu Chen; Yi-Ying Jan; Tse-Yu Lee 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

A pilot study of transcatheter arterial

A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma

✍ Man-Fung Yuen; Clara Gaik-Cheng Ooi; Chee-Kin Hui; Wai-Man Wong; Benjamin Chun-Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

## Abstract ## BACKGROUND Systemic, high–dose interferon‐α treatment given three times per week subcutaneously induces tumor regression in approximately 30% of patients with inoperable hepatocellular carcinoma (HCC). The objective of the current study was to determine the efficacy and safety of tr

Prognostic factors in the treatment of h

Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion

✍ Yasuyuki Yamashita; Mutsumasa Takahashi; Yukinori Koga; Ryuiti Saito; Seito Nana 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Transcatheter arterial embolization with

Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study

✍ Jinn-Ming Chang; Wen-Sheng Tzeng; Huay-Ben Pan; Chien-Fang Yang; Kwok-Hung Lai 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 2 views

Treatment of hepatocellular carcinoma by

Treatment of hepatocellular carcinoma by simultaneous embolization of the hepatic artery and the portal veins

✍ Charles J. Lightdale 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Transcatheter arterial embolization (TAE) is an effective means of treatment in primary hepatocellular carcinoma (HCC). However, in many cases of HCC the tumor recurs after treatment. In an attempt to obtain complete tumor necrosis, the authors studied the clinical and histologic effect of simultane

Limitation of transcatheter arterial che

Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma. A study in resected cases

✍ Chikazumi Kuroda; Masami Sakurai; Morito Monden; Taro Marukawa; Takuya Hosoki; K 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB